Sandoz Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sandoz Private Limited Pharmaceutical Export Portfolio Dataset — 25 Products, $159.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sandoz Private Limited — Pharmaceutical Exporter Profile (2026) | 25 Products, $159.4M Trade | TransData Nexus

Sandoz Private Limited

Indian Pharmaceutical Exporter · Immunosuppressants Specialist · $159.4M Total Trade · DGFT Verified

Sandoz Private Limited is an Indian pharmaceutical exporter with a total trade value of $159.4M across 25 products in 15 therapeutic categories. Based on 3,677 verified export shipments from Indian Customs (DGFT) records, Sandoz Private Limited is the #1 Indian exporter in 4 products including Tacrolimus, Voriconazole, Loratadine. Top exports include Tacrolimus ($36.9M), Apixaban ($15.6M), Citalopram ($12.9M).

Sandoz Private Limited — Export Portfolio & Destination Treemap

Sandoz Private Limited pharmaceutical export portfolio — 25 products across 15 therapeutic categories. Source: Indian Customs (DGFT).

Who is Sandoz Private Limited? — Company Overview & Market Position

Sandoz Private Limited, incorporated on March 30, 1995, is a private limited company based in Maharashtra, India. Its Corporate Identification Number (CIN) is U24230MH1995PTC086989, and it is registered under the Registrar of Companies, Mumbai. The company specializes in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products.

The registered office is located at Kalwe MIDC, Plot No. 8-A/2, 8/B, TTC Industrial Area, Kalwe Block, Village Dighe, Navi Mumbai, Maharashtra 400708, India. Sandoz Private Limited operates as a non-government company limited by shares, with an authorized capital of ₹50,000,000 and a paid-up capital of ₹32,000,000.

What Does Sandoz Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Tacrolimus$36.9M 2Apixaban$15.6M

Product Portfolio — Top 25 by Export Value

Sandoz Private Limited exports 25 pharmaceutical products across 15 therapeutic categories. Market leader (#1 exporter) in 4 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Tacrolimus	Immunosuppressants	$36.9M	737	18.3%	1
2	Apixaban	Cardiovascular	$15.6M	500	8.7%	4
3	Citalopram	CNS & Psychiatric	$12.9M	281	5.1%	7
4	Escitalopram	CNS & Psychiatric	$12.9M	281	6.6%	4
5	Gabapentin	CNS & Psychiatric	$11.2M	224	1.3%	2
6	Mycophenolate	Immunosuppressants	$10.2M	204	3.0%	4
7	Kit	Medical Devices & Diagnostics	$7.8M	175	1.8%	6
8	Valsartan	Cardiovascular	$7.5M	150	3.8%	3
9	Voriconazole	Advanced Antifungals	$7.3M	146	23.4%	1
10	Sitagliptin	Diabetes & Endocrine	$6.5M	129	8.5%	2
11	Clopidogrel	Cardiovascular	$5.3M	105	2.1%	9
12	Allopurinol	Lipid & Metabolism	$4.8M	97	1.0%	4
13	Loratadine	Antihistamines & Allergy	$4.5M	89	2.6%	1
14	Lansoprazole	Gastrointestinal	$3.5M	69	1.2%	1
15	Furosemide	Diuretics	$2.3M	88	3.3%	7
16	Alprazolam	CNS & Psychiatric	$2.0M	60	12.2%	2
17	Ezetimibe	Lipid & Metabolism	$1.6M	32	0.3%	12
18	Rifampicin	Advanced Antibiotics	$1.5M	57	0.1%	8
19	Carvedilol	Cardiovascular	$1.5M	69	1.5%	12
20	Montelukast	Respiratory	$1.3M	26	0.8%	13
21	Dapagliflozin	Advanced Diabetes Medications	$1.1M	44	2.3%	9
22	Nitrofurantoin	Advanced Antibiotics	$500.0K	10	1.5%	5
23	Lenvatinib	Advanced Oncology	$316.5K	41	14.8%	2
24	Efavirenz	Antivirals	$283.0K	6	0.5%	12
25	Olaparib	Advanced Oncology	$161.9K	57	17.6%	2

Sandoz Private Limited exports 25 pharmaceutical products across 15 therapeutic categories with a total export value of $159.4M. The company is the #1 Indian exporter in 4 products: Tacrolimus, Voriconazole, Loratadine, Lansoprazole. The top category is Immunosuppressants (29.5% of portfolio), followed by CNS & Psychiatric (24.5%), reflecting a diversified portfolio where the top 5 products account for only 56.1% of total value.

Sandoz Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sandoz Private Limited's manufacturing facility is situated in Navi Mumbai, Maharashtra. The plant specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding production capacities and additional manufacturing sites are not publicly disclosed.

3Key Leadership

As of March 2026, the board of directors of Sandoz Private Limited includes:

Sudhir Trambakrao Bhandare
Sanjeev Shrivastav
Rajeev Ranjan
Nishith Laxmikant Vaidya

The company does not publicly disclose the specific roles of these directors.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Sandoz Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Sandoz Private Limited exports finished pharmaceutical formulations to various international markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has secured regulatory approvals for its products in these regions, facilitating market access. Specific details regarding individual product approvals and regulatory filings are not publicly disclosed.

2Emerging Markets

Sandoz Private Limited has expanded its presence in emerging markets across Africa, Latin America, and Southeast Asia. The company has obtained WHO prequalification for certain products, enabling access to these regions. Specific details regarding product approvals and market penetration strategies are not publicly disclosed.

3Geographic Strategy

Sandoz Private Limited demonstrates a diversified geographic strategy by exporting to both developed and emerging markets. This approach mitigates concentration risk and aligns with the company's strategic direction to enhance global market presence.

Sandoz Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Sandoz Private Limited's manufacturing facility is registered with the U.S. Food and Drug Administration (FDA). The company has filed Abbreviated New Drug Applications (ANDAs) for various products, and its Drug Master Files (DMFs) are accessible to the FDA. Specific details regarding inspection history and individual product approvals are not publicly disclosed.

2WHO & EU GMP

Sandoz Private Limited has obtained WHO prequalification for certain products, ensuring compliance with international quality standards. The company also holds EU Good Manufacturing Practice (GMP) certificates, affirming adherence to European manufacturing standards. Specific details regarding individual product certifications are not publicly disclosed.

3CDSCO & Indian Regulatory

Sandoz Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has obtained approvals from state drug controllers. The company has received export No Objection Certificates (NOCs) from the Directorate General of Foreign Trade (DGFT), facilitating international trade. Specific details regarding individual product approvals and regulatory compliance are not publicly disclosed.

Sandoz Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Sandoz Private Limited operates in a competitive landscape, with several multinational and domestic pharmaceutical companies offering similar products. The company's market share varies across different therapeutic categories, with notable positions in immunosuppressants, CNS & psychiatric, and cardiovascular segments. Specific market share comparisons and head-to-head analyses are not publicly disclosed.

2Key Differentiators

Sandoz Private Limited's key differentiators include its diversified product portfolio, strong presence in multiple therapeutic categories, and adherence to international quality standards. The company's ability to secure regulatory approvals across various markets enhances its competitive advantage.

3Strategic Position

Sandoz Private Limited's current strategic direction focuses on the production and export of generic pharmaceutical formulations. The company's future outlook includes potential expansion into specialty drugs and biosimilars, leveraging its manufacturing capabilities and regulatory expertise.

Buyer Due Diligence Brief — Evaluating Sandoz Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sandoz Private Limited has a strong track record in pharmaceutical manufacturing, with consistent export volumes and adherence to international quality standards. The company's reliability is indicated by its regulatory approvals and certifications from authorities such as the FDA, WHO, and EU GMP.

2Certifications to Verify

Importers should verify the following certifications when considering Sandoz Private Limited as a supplier:

FDA Registration: Confirm the company's registration status and product approvals through the FDA's official database.

WHO-GMP Certification: Obtain copies of WHO prequalification certificates for relevant products.

EU GMP Certification: Request EU GMP certificates for applicable products.

Frequently Asked Questions — Sandoz Private Limited

How many pharmaceutical products does Sandoz Private Limited export from India?

Sandoz Private Limited exports 25 pharmaceutical products across 15 therapeutic categories. The top exports are Tacrolimus ($36.9M), Apixaban ($15.6M), Citalopram ($12.9M), Escitalopram ($12.9M), Gabapentin ($11.2M). Total export value is $159.4M.

What is Sandoz Private Limited's total pharmaceutical export value?

Sandoz Private Limited's total pharmaceutical export value is $159.4M, based on 3,677 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Sandoz Private Limited the #1 Indian exporter?

Sandoz Private Limited is the #1 Indian exporter in 4 products: Tacrolimus (18.3% market share), Voriconazole (23.4% market share), Loratadine (2.6% market share), Lansoprazole (1.2% market share).

What therapeutic categories does Sandoz Private Limited cover?

Sandoz Private Limited exports across 15 therapeutic categories. The largest are Immunosuppressants (29.5%, 2 products), CNS & Psychiatric (24.5%, 4 products), Cardiovascular (18.7%, 4 products).

Get Full Sandoz Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.